Icosavax
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Icosavax to support the development of a new nanoparticle COVID-19 vaccine.
- Date of Investment:
- 08/2020
- Read More:
- Open Philanthropy Page
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Icosavax to support the development of a new nanoparticle COVID-19 vaccine.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in VST Bio to support the development of a novel treatment for stroke and traumatic brain disease.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Kainomyx to support the development and production of a new antimalarial drug.